Top compounds associated with response to TSTD2


Feature Type Standardized
Nominal ANOVA
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.13 1e-05
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.13 1e-05
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.13 7e-05
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.14 8e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.13 8e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.15 8e-05
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.13 0.0001
Download CSV